A Phase 4, Randomized, Single-blind Trial to Evaluate Safety and Immunogenicity of a 23-Valent Pneumococcal Polysaccharide Vaccine When Administered Simultaneously With Trivalent Inactivated Influenza Vaccine in Healthy Children Aged 3-7years and Healthy Adults 65 Aged 50-65years.
Phase of Trial: Phase IV
Latest Information Update: 25 Sep 2015
At a glance
- Drugs Pneumococcal vaccine (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections; Pneumococcal infections
- Focus Therapeutic Use
- 24 Feb 2014 New trial record